Bernice Y. Man, PharmD, BCPS, CPHQ, CSP, DPLA ([email protected]), is a clinical pharmacy manager in specialty pharmacy at University of Chicago Medicine. She has experience in multiple areas of specialty pharmacy, including direct patient care in various clinical service lines, clinical and operational management, accreditation, quality, safety, and advocacy.
Man has a Bachelor’s degree in economics from the University of Chicago, earned her PharmD from Chicago State University College of Pharmacy, completed a PGY1/PGY2 health-system pharmacy administration residency at the University of Chicago Medicine, and is in the Master of Business Administration program at the University of Chicago Booth School of Business.
Man is a current member of the Section of Specialty Pharmacy Practitioners (SSPP) Advisory Group (SAG) on Business Development and is past Chair of the SAG on Workforce Development. She has been an active member of ASHP, serving as a member of the ASHP Council on Public Policy, delegate from Illinois to the ASHP House of Delegates where she proposed new policies for House consideration and subsequent approval, and faculty for the ASHP Specialty Pharmacy Certificate.
Policy gives our profession power and influence to serve patients from a pharmacoequity perspective. The inspiration for policy, advocacy and helping underserved patients began in 2013 while completing the Albert Schweitzer Fellowship during pharmacy school and has grown in the past seven years I have dedicated to specialty pharmacy. A persistent issue we face is too many of our patients have financial and access barriers to their specialty medications.
Our Section has done amazing work in creating resources and establishing best practices for HSSPs. We advocate for patients with every prior authorization, appeal letter, and financial assistance application. Despite these individual patient advocacy efforts, we continue to see how other healthcare companies assert control over the specialty medication continuum, whether through payer-mandated drug-distribution models or threats to the 340B program.
Being a delegate from Illinois to the ASHP House of Delegates for the past 4 years and a past member of the ASHP Council on Public Policy have afforded me experience with how we can assert influence in our healthcare system, and I truly believe policy is one way we can accomplish this aim. My vision is to add legislative and policy efforts to our Section’s areas of focus and given my passion for advocacy, I would be grateful to join our Section’s leadership with this vision in mind. Thank you for considering my candidacy for Chair as it is truly an honor to be a candidate for our Section.